Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCVS Group Regulatory News (CVSG)

Share Price Information for CVS Group (CVSG)

Share Price is delayed by 15 minutes
Get Live Data
1,181.00    8.00 (0.68%)
Bid:
1,174.00
Ask:
1,179.00
Spread: 5.00 (0.426%)
Market Cap: £819.00m
CVSG Live PriceLast checked at - London Stock Exchange

Intraday CVS Group Share Chart

Director/PDMR Dealing

31 Mar 2017 11:55

RNS Number : 1884B
CVS Group plc
31 March 2017
 

31 March 2017

 

CVS Group plc

("CVS" or the "Company")

 

 

Director/PDMR Dealing

 

CVS, one of the UK's leading provider of integrated veterinary services for small and large animals, announces that Nick Perrin, Finance Director of the Company, has purchased 3,714 ordinary shares of 0.2p each in the Company ("Ordinary Shares"). As a result, Mr Perrin holds 32,000 Ordinary Shares, representing 0.05 per cent. of the total voting rights of the Company.

 

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

 

Contacts:

CVS Group plc

Simon Innes, Chief Executive

Nick Perrin, Finance Director

 

Tel: 01379 644 288

 

N+1 Singer (Nominated Adviser & Broker)

Aubrey Powell

Liz Yong

James Hopton

Tel: 020 7496 3000

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Nick Perrin

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Finance Director

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

CVS Group plc

b)

 

LEI

 

 

213800J41XDQ2NX48O05

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary shares of 0.2 pence each

 

 

GB00B2863827

 

b)

 

Nature of the transaction

 

 

Purchases of Ordinary Shares through a joint account held by the PDMR and PCA

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

(i) 1080.00 pence

3,714

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

 

- Price

 

 

 

n/a

e)

 

Date of the transaction

 

 

31 March 2017

f)

 

Place of the transaction

 

 

London Stock Exchange (XLON)

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHLLFEIVSILVID
Date   Source Headline
4th Nov 20202:30 pmRNSPosting of Annual Report & Notice of AGM
30th Oct 20205:09 pmRNSExercise of Options
30th Sep 20207:00 amRNSExercise of Options
24th Sep 20207:00 amRNSFinal Results for the year ended 30 June 2020
4th Sep 202012:02 pmRNSPrice Monitoring Extension
28th Aug 20207:00 amRNSExercise of Options
18th Aug 20203:54 pmRNSHolding(s) in Company
31st Jul 20207:00 amRNSExercise of Options
24th Jul 20207:00 amRNSTrading Update
16th Jul 20207:00 amRNSBoard Appointment
30th Jun 202011:15 amRNSExercise of Options
26th Jun 20207:00 amRNSChange of Company Secretary
9th Jun 202012:29 pmRNSDirector/PDMR Shareholding
1st Jun 202011:50 amRNSExercise of Options
7th May 20209:10 amRNSHolding(s) in Company
30th Apr 202010:25 amRNSExercise of Options
14th Apr 20204:00 pmRNSHolding(s) in Company
9th Apr 202012:23 pmRNSHolding(s) in Company
2nd Apr 20202:29 pmRNSHolding(s) in Company
31st Mar 20201:42 pmRNSExercise of Options
30th Mar 202011:45 amRNSDirector/PDMR Shareholding
27th Mar 20202:52 pmRNSDirector/PDMR Shareholding
27th Mar 202012:02 pmRNSPrice Monitoring Extension
27th Mar 20209:54 amRNSFormatting Replacement: Interim Results
27th Mar 20207:00 amRNSInterim Results
20th Mar 20204:37 pmRNSPrice Monitoring Extension
16th Mar 20207:00 amRNSHolding(s) in Company
12th Mar 20209:34 amRNSHolding(s) in Company
9th Mar 20205:01 pmRNSHolding(s) in Company
9th Mar 20209:18 amRNSHolding(s) in Company
6th Mar 20205:27 pmRNSHolding(s) in Company
6th Mar 20202:47 pmRNSHolding(s) in Company
28th Feb 20207:00 amRNSExercise of Options
7th Feb 20207:00 amRNSTrading Update
31st Jan 20205:47 pmRNSOption exercise and block listing update
27th Jan 20204:12 pmRNSHolding(s) in Company
24th Jan 20204:22 pmRNSHolding(s) in Company
22nd Jan 20205:08 pmRNSHolding(s) in Company
20th Jan 20207:00 amRNSHolding(s) in Company
10th Jan 20203:46 pmRNSLong Term Incentive Plan Awards - replacement
10th Jan 20209:27 amRNSHolding(s) in Company
8th Jan 20203:57 pmRNSLong Term Incentive Plan Awards
7th Jan 20204:58 pmRNSHolding(s) in Company
6th Jan 202012:02 pmRNSPrice Monitoring Extension
2nd Jan 20207:00 amRNSHolding(s) in Company
23rd Dec 20199:29 amRNSHolding(s) in Company
20th Dec 20193:15 pmRNSLong Term Incentive Plan Awards
12th Dec 20199:39 amRNSHolding(s) in Company
2nd Dec 201912:17 pmRNSHolding(s) in Company
29th Nov 20197:00 amRNSBoard Appointments

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.